Advanced Search Results For "Dobrowolska, Krystyna"
Your filters
Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings
Publication Type: Academic Journal
Source(s): Journal of Clinical Medicine, Vol 12, Iss 2371, p 2371 (2023)
Abstract: Continuous evaluation of real-world treatment effectiveness of COVID-19 medicines is required due to the ongoing evolution of SARS-CoV-2 and the possible emergence of resistance. Therefore, this study aimed to analyze, in a retrospective manner, the ou...
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Publication Type: Academic Journal
Source(s): Viruses, Vol 15, Iss 149, p 149 (2023)
Abstract: The COVID-19 pandemic proceeds in waves, with variable characteristics of the clinical picture resulting from the evolution of the SARS-CoV-2 virus. This study aimed to compare the epidemiological characteristics, symptomatology, and outcomes of the di...
Clinical characteristics and antiviral therapy in patients infected with hepatitis C virus in the interferon -free era.
Publication Type: Academic Journal
Source(s): Polish Archives of Internal Medicine. Sep2022, Vol. 132 Issue 9, p1-11. 11p.
Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings.
Publication Type: Academic Journal
Source(s): Journal of Clinical Medicine; Mar2023, Vol. 12 Issue 6, p2371, 16p
Abstract: Copyright of Journal of Clinical Medicine is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or e...
Genotype 4 hepatitis C virus-a review of a diverse genotype.
Publication Type: Academic Journal
Source(s): Advances in Medical Sciences (Elsevier Inc.). Mar2023, Vol. 68 Issue 1, p54-59. 6p.
Abstract: Hepatitis C virus (HCV) infection remains a major health problem and one of the leading causes of chronic liver disease worldwide. The purpose of this paper was to summarize knowledge about the epidemiology of HCV genotype (GT) 4 infection, similaritie...
Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
Publication Type: Academic Journal
Source(s): Journal of Clinical Medicine, Vol 11, Iss 389, p 389 (2022)
Abstract: The introduction of the direct-acting antivirals (DAA) has substantially improved the effectiveness of the therapy in patients with chronic hepatitis C. We aimed to compare the efficacy of pangenotypic and genotype-specific DAA in the cohort of genotyp...
Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?
Publication Type: Academic Journal
Source(s): Viruses, Vol 14, Iss 96, p 96 (2022)
Abstract: Difficult-to-treat populations with chronic hepatitis C (CHC), in the era of interferon treatment, included patients with liver cirrhosis, kidney impairment, treatment-experienced individuals, and those coinfected with the human immunodeficiency virus....
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database.
Publication Type: Academic Journal
Source(s): Viruses (1999-4915); Jan2023, Vol. 15 Issue 1, p149, 13p
Abstract: Copyright of Viruses (1999-4915) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email arti...
Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance.
Publication Type: Academic Journal
Source(s): Pharmacological Reports; Dec2022, Vol. 74 Issue 6, p1279-1285, 7p
Correction: Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance.
Publication Type: Academic Journal
Source(s): Pharmacological Reports; Dec2022, Vol. 74 Issue 6, p1328-1328, 1p